Peter Moran
Gründer bei Singular ID Pte Ltd.
Profil
Peter Moran is Chief Technology Officer and a Director Singular ID Pte Ltd.
Previously, he was a Senior Scientist of IMRE.
Dr. Morean received a PhD in Engineering and an MS degree in Applied Mathematics and Engineering from Brown University.
Aktive Positionen von Peter Moran
Unternehmen | Position | Beginn |
---|---|---|
Singular ID Pte Ltd.
Singular ID Pte Ltd. Packaged SoftwareTechnology Services Singular ID Pte Ltd. manufactures and supplies security systems and products. The company was founded in December 2004 and is headquartered in Singapore. | Gründer | - |
Ehemalige bekannte Positionen von Peter Moran
Unternehmen | Position | Ende |
---|---|---|
Cypress Bioscience, Inc.
Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | Corporate Officer/Principal | - |
Ausbildung von Peter Moran
Brown University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Singular ID Pte Ltd.
Singular ID Pte Ltd. Packaged SoftwareTechnology Services Singular ID Pte Ltd. manufactures and supplies security systems and products. The company was founded in December 2004 and is headquartered in Singapore. | Technology Services |
Cypress Bioscience, Inc.
Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | Health Technology |